Pulmonary Atresia Birth Defects
The leading law firm of Alonso Krangle LLP is investigating potential lawsuits on behalf of families whose child may have been born with pulmonary atresia because of their mother’s use of a selective serotonin reuptake inhibitor (SSRI) antidepressant during pregnancy. A growing body of research has linked the use of SSRI antidepressants to birth defects, including pulmonary atresia.
SSRIs that may be associated with the occurrence of pulmonary atresia include:
The birth defect lawyers at Alonso Krangle LLP are leaders in defective drug litigation, and understand the difficult road families of children with pulmonary atresia must travel. If your child’s suffering was caused by an SSRI antidepressant taken during pregnancy, your family deserves compensation from the maker of that drug. Filing a SSRI pulmonary atresia lawsuit could enable you to obtain money damages for your child’s current and future medical needs, pain and suffering, and emotional distress. The birth defect lawyers at Alonso Krangle LLP are currently offering free lawsuit consultations in all 50 states to any family who believes an SSRI caused their baby to suffer from pulmonary atresia. To learn more about obtaining justice for your baby, please contact the SSRI birth defect lawyers at Alonso Krangle LLP today.
What is Pulmonary Atresia?
Pulmonary atresia occurs because the heart’s pulmonary valve, which is found between the right ventricle and the pulmonary artery, is unable to open properly. As a result, blood cannot flow forward from the right ventricle to the lungs. Pulmonary atresia is the result of abnormal development of the fetal heart during the first 8 weeks of pregnancy.
Newborn infants with pulmonary atresia usually become cyanotic (blue) within the first few days of birth. Other symptoms of pulmonary atresia may include:
- rapid breathing
- difficulty breathing
- pale, cool, or clammy skin
Children with pulmonary atresia are usually admitted to the intensive care unit (ICU) or special care nursery once symptoms appear. They may be placed on oxygen, and possibly even on a ventilator, to assist breathing. Intravenous (IV) medications may be given to help the heart and lungs function more efficiently.
Treatment for pulmonary atresia in a newborn begins with interventions to stabilize the infant. A cardiac catheterization procedure can be used to diagnose pulmonary atresia, and at the same time, a procedure called balloon atrial septostomy may be performed to improve mixing of oxygen-rich (red) blood and oxygen-poor (blue) blood between the right and left atria. An intravenous medication called prostaglandin E1 is then given to keep the ductus arteriosus from closing.
Ultimately, surgery is necessary to improve blood flow to the lungs on a permanent basis. The exact type of surgery needed depends on a number of factors including the size of the right ventricle and whether there is a communication between the right and left ventricles (a ventricular septal defect or VSD).
Learn more About Filing an SSRI Pulmonary Atresia Lawsuit
If your child was born with pulmonary atresia, and you believe an SSRI, including Celexa, Lexapro, Paxil, Prozac, or Zoloft, might be to blame, you may be eligible to file a lawsuit against the manufacturers of these medications. To learn more about the legal options available to you, please contact the SSRI birth defect lawyers at Alonso Krangle LLP by filling out our online form or calling 1-800-403-6191.